Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Correction: AvePoint Raises FY2025 Sales Guidance from $397.400M-$405.400M to $406.600M-$410.600M vs $401.424M Est

Author: Benzinga Newsdesk | August 07, 2025 05:03pm

For the full year 2025, the Company now expects:

  • Total ARR of $412.8 million to $418.8 million, or year-over-year growth of 26% to 28%. Adjusted for FX, the Company expects ARR growth of 24% to 26%.
  • Total revenues of $406.6 million to $410.6 million, or year-over-year growth of 23% to 24%. On a constant currency basis, the Company expects revenue growth of 21% to 22%.
  • Non-GAAP operating income of $68.3 million to $70.8 million.

Posted In: AVPT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist